Reviva Pharmaceuticals Revenue and Competitors

Location

$41.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Reviva Pharmaceuticals's estimated annual revenue is currently $2.2M per year.(i)
  • Reviva Pharmaceuticals's estimated revenue per employee is $116,368
  • Reviva Pharmaceuticals's total funding is $41.4M.

Employee Data

  • Reviva Pharmaceuticals has 19 Employees.(i)
  • Reviva Pharmaceuticals grew their employee count by 6% last year.

Reviva Pharmaceuticals's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
VP QualityReveal Email/Phone
3
Head CMCReveal Email/Phone
4
VP, Regulatory AffairsReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director Clinical Trials OperationsReveal Email/Phone
7
Quality Assurance ManagerReveal Email/Phone
8
President and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Reviva Pharmaceuticals?

Reviva is developing a portfolio of internally discovered next generation safe and effective therapeutic drugs. Our research programs are focused on the central nervous system (CNS), cardiovascular (CV), metabolic and inflammatory indications. We develop small molecule therapeutics using chemical genomics based technology platform and proprietary chemistries. Reviva's products are new chemical entities (NCEs), and are designed to be safe, highly potent, selective, and orally bioavailable for improved patient compliance. Our product candidates and their current status are summarized in the following chart.

keywords:N/A

$41.4M

Total Funding

19

Number of Employees

$2.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Reviva Pharmaceuticals News

2022-04-13 - Short Interest in Reviva Pharmaceuticals Holdings, Inc ...

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation...

2022-04-06 - Reviva Pharmaceuticals Holdings, Inc. (RVPH) is down 12.04% Thursday In Premarket Trading

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is down 12.04% Thursday In Premarket Trading. Thursday, April 07, 2022 06:49 AM | InvestorsObserver Analysts.

2022-03-22 - Reviva Pharmaceuticals Holdings, Inc. Interview to Air on ...

Reviva is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for...

2021-09-02 - Reviva Pharmaceuticals : to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

CUPERTINO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascul ...

2021-05-27 - REVIVA PHARMACEUTICALS HOLDINGS, INC. Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering

CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M190%N/A
#2
$1.7M19N/AN/A
#3
$1.7M1919%N/A
#4
$1.7M190%N/A
#5
$0.6M19-49%$16M